The Implications of Human Stem Cell Differentiation to Endothelial Cell Via Fluid Shear Stress in Cardiovascular Regenerative Medicine: A Review
Keywords: -catenin signaling pathway; Bare metal stents; Cardiovascular; Caveolin; Cl- channel; Cytoskeleton & tensegrity model; ENaC; Epigenetics; FK-binding proteins (FKBPs); GPCR; Glycocalyx; HDAC7; HPB EPC; Human PDEC; Human PDMC; Integrin; JAK-STAT pathway; K+ channel; Kartagener syndrome; Laminar,15 d; Mechanotransduction; Neutropenia; Paclitaxel; Pharmacology; Primary cilia; Shear stress; Sirolimus; Stem cell; TRP; VEGF; Wnt5a; band-aid; ciliary dyskinesia; circulatory loop system (CLS); coronary valve replacements; drug-eluting stents; dynein; els (generic); endothelializa-tion potential; everolimus; growth factor (VEGF); hESC-derived EC; inhibitor of DNA; laminar fluid shear stress; mammalian target-of-rapamycin; matrix met-alloproteinase-1; nanocomposites; nitric oxide synthase (eNOS); percutaneous; plasminogen activator inhibitor-1; rapamycin; superoxide dismutase; vascular restenosis; zotarolimus
Document Type: Research Article
Publication date: 01 November 2010
- Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.
Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism. - Editorial Board
- Information for Authors
- Subscribe to this Title
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content